Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.
Nishio M, Murakami S, Kawakami H, Okishio K, Tamiya M, Kobayashi H, Fujimoto D, Sugawara S, Kozuki T, Oya Y, Izumi H, Shiroyama T, Satouchi M, Yamamoto N, Kaname S, Matsuoka D, Otake Y, Takase T, Semba T, Azuma K.
Nishio M, et al. Among authors: kozuki t.
Cancer Res Commun. 2024 Jan 29;4(1):226-235. doi: 10.1158/2767-9764.CRC-23-0313.
Cancer Res Commun. 2024.
PMID: 38181055
Free PMC article.
Clinical Trial.